Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?
Correct staging is the most crucial for the treatment outcome in cancer management. Molecular imaging with 18F-fluoroestradiol (FES) positron emission tomography-computed tomography (PET-CT) targets estrogen receptor (ER) and may have a higher incremental value in diagnosis by aiding specificity. We...
Main Authors: | Manoj Gupta, Anupama Datta, Partha S Choudhury, Maria Dsouza, Ullas Batra, Anil Mishra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | World Journal of Nuclear Medicine |
Subjects: | |
Online Access: | http://www.wjnm.org/article.asp?issn=1450-1147;year=2017;volume=16;issue=2;spage=133;epage=139;aulast=Gupta |
Similar Items
-
Recurrent Proliferating Trichilemmal Tumor with Malignant Change on the F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Eun Ha Moon, et al.
Published: (2016-06-01) -
18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY IN CANCER PATIENTS: A WHOLE-BODY EXAMINATION PROCEDURE
by: O. V. Mukhortova, et al.
Published: (2014-09-01) -
Irritated seborrhoeic keratosis masquerading as malignancy on 18F-fluorodeoxyglucose positron emission tomography–computed tomography
by: Punit Sharma
Published: (2021-01-01) -
F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart
by: Eunjung Kong
Published: (2021-04-01) -
Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)